Loading...
Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction?
Introduction: Tamoxifen is associated with a twofold increased risk of thromboembolic events. Third generation aromatase inhibitors (AIs), such as letrozole, anastrozole, and exemestane have therefore replaced tamoxifen in the adjuvant therapy of hormone receptor-positive breast cancer. A retrospect...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
German Medical Science GMS Publishing House
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3575563/ https://ncbi.nlm.nih.gov/pubmed/23423877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3205/000173 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|